Edap Tms (NASDAQ:EDAP) Upgraded at StockNews.com

StockNews.com upgraded shares of Edap Tms (NASDAQ:EDAP) from a sell rating to a hold rating in a research note published on Tuesday.

Separately, HC Wainwright restated a buy rating and issued a $19.00 price objective on shares of Edap Tms in a report on Monday, July 22nd.

Edap Tms Trading Up 0.5 %

Shares of EDAP opened at $4.20 on Tuesday. The stock has a market capitalization of $155.84 million, a P/E ratio of -7.78 and a beta of 0.45. The company has a quick ratio of 2.00, a current ratio of 2.62 and a debt-to-equity ratio of 0.08. The firm has a fifty day simple moving average of $4.99 and a two-hundred day simple moving average of $6.20. Edap Tms has a twelve month low of $3.60 and a twelve month high of $8.57.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings data on Thursday, May 16th. The medical equipment provider reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.03). Edap Tms had a negative return on equity of 31.44% and a negative net margin of 30.12%. The company had revenue of $16.13 million during the quarter, compared to the consensus estimate of $16.22 million. On average, research analysts anticipate that Edap Tms will post -0.51 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of EDAP. Miracle Mile Advisors LLC bought a new position in shares of Edap Tms in the 1st quarter worth about $136,000. Roubaix Capital LLC bought a new position in shares of Edap Tms in the 1st quarter worth about $169,000. Virtu Financial LLC bought a new position in shares of Edap Tms in the 1st quarter worth about $82,000. Finally, Commonwealth Equity Services LLC increased its stake in shares of Edap Tms by 5.9% in the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after acquiring an additional 4,000 shares in the last quarter. 62.74% of the stock is currently owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.